Register entry
- Registered sites
- 0
- Active NDC listings
- 11
- Live patents
- 12
- Countries
- 0
Catalogue
Drug listings by form and route
1111 active NDC listings: 11 human prescription drug. By marketing category: NDA 11.
| Dosage form | NDCs |
|---|---|
| kit | 5 |
| tablet, film coated | 5 |
| tablet | 1 |
| Route | NDCs |
|---|---|
| oral | 11 |
| Labeller name on the listing | NDCs |
|---|---|
| sk life science, inc. | 11 |
Exclusivity
Patents and exclusivities
12| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 7598279 | XCOPRIcenobamate | substance | Oct 2032 |
| 11654133 | XCOPRIcenobamate | use | Jun 2039 |
Catalogue
Marketed products
11| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Xcopri | cenobamate | tablet, film coated, oral | 71699-025NDA |
| Xcopri | cenobamate | tablet, film coated, oral | 71699-050NDA |
| Xcopri | cenobamate | tablet, film coated, oral | 71699-100NDA |
| Xcopri | cenobamate | tablet, film coated, oral | 71699-150NDA |
| Xcopri | cenobamate | tablet, film coated, oral | 71699-200NDA |
| Xcopri | cenobamate | tablet, oral | 71699-204NDA |
| Xcopri Maintenance Pack | cenobamate | kit, oral | 71699-103NDA |
| Xcopri Maintenance Pack | cenobamate | kit, oral | 71699-104NDA |
| Xcopri Titration Pack | cenobamate | kit, oral | 71699-201NDA |
| Xcopri Titration Pack | cenobamate | kit, oral | 71699-202NDA |
| Xcopri Titration Pack | cenobamate | kit, oral | 71699-203NDA |
Compare
Other companies listing cenobamate
- SK BIOTEK2 sites · 10 NDC
Enquiry
Common questions
- Is SK Life Science, Inc. FDA approved?
- SK Life Science, Inc. holds no registered establishment of its own; 11 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does SK Life Science, Inc. make?
- 11 products are listed under SK Life Science, Inc. in the openFDA NDC Directory, most often as kit; tablet, film coated; tablet. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.